Drägerwerk AG & Co. KGaA (pref) (DRW3) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.037x

Based on the latest financial reports, Drägerwerk AG & Co. KGaA (pref) (DRW3) has a cash flow conversion efficiency ratio of 0.037x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€62.00 Million ≈ $72.49 Million USD) by net assets (€1.66 Billion ≈ $1.94 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Drägerwerk AG & Co. KGaA (pref) net asset quality index to measure how much of total assets are equity-financed.

Drägerwerk AG & Co. KGaA (pref) - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Drägerwerk AG & Co. KGaA (pref)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check DRW3 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Drägerwerk AG & Co. KGaA (pref) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Drägerwerk AG & Co. KGaA (pref) ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
SK Reit Co Ltd
KO:395400
N/A
O-I Glass Inc
NYSE:OI
-0.205x
Zhejiang Songyuan Automotive Safety
SHE:300893
0.019x
Darma Henwa Tbk
JK:DEWA
0.091x
Equital
TA:EQTL
0.020x
Guangdong Goworld Co Ltd
SHE:000823
0.025x
SFL Corporation Ltd
NYSE:SFL
0.067x
Hotel Shilla
KO:008770
-0.137x

Annual Cash Flow Conversion Efficiency for Drägerwerk AG & Co. KGaA (pref) (2013–2025)

The table below shows the annual cash flow conversion efficiency of Drägerwerk AG & Co. KGaA (pref) from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Drägerwerk AG & Co. KGaA (pref).

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €1.63 Billion
≈ $1.90 Billion
€238.33 Million
≈ $278.63 Million
0.146x +34.41%
2024-12-31 €1.54 Billion
≈ $1.80 Billion
€167.31 Million
≈ $195.60 Million
0.109x -19.11%
2023-12-31 €1.41 Billion
≈ $1.65 Billion
€189.68 Million
≈ $221.75 Million
0.135x +223.13%
2022-12-31 €1.32 Billion
≈ $1.54 Billion
€-144.23 Million
≈ $-168.62 Million
-0.109x -135.80%
2021-12-31 €1.26 Billion
≈ $1.47 Billion
€384.89 Million
≈ $449.97 Million
0.305x -31.37%
2020-12-31 €1.03 Billion
≈ $1.21 Billion
€459.98 Million
≈ $537.76 Million
0.445x +191.27%
2019-12-31 €1.08 Billion
≈ $1.26 Billion
€164.42 Million
≈ $192.22 Million
0.153x +3936.11%
2018-12-31 €1.08 Billion
≈ $1.26 Billion
€4.09 Million
≈ $4.78 Million
0.004x -97.18%
2017-12-31 €1.07 Billion
≈ $1.25 Billion
€143.34 Million
≈ $167.57 Million
0.134x -31.07%
2016-12-31 €1.00 Billion
≈ $1.17 Billion
€195.32 Million
≈ $228.35 Million
0.195x +361.89%
2015-12-31 €945.93 Million
≈ $1.11 Billion
€39.86 Million
≈ $46.60 Million
0.042x -79.90%
2014-12-31 €896.61 Million
≈ $1.05 Billion
€187.98 Million
≈ $219.77 Million
0.210x +150.33%
2013-12-31 €815.97 Million
≈ $953.95 Million
€68.34 Million
≈ $79.90 Million
0.084x --

About Drägerwerk AG & Co. KGaA (pref)

F:DRW3 Germany Medical Devices
Market Cap
$1.10 Billion
€937.40 Million EUR
Market Cap Rank
#8377 Global
#1118 in Germany
Share Price
€109.00
Change (1 day)
+4.01%
52-Week Range
€62.30 - €109.00
All Time High
€109.00
About

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more